Veracyte, Inc. (VCYT)
44.06
+2.59
(+6.25%)
USD |
NASDAQ |
Aug 25, 16:00
44.06
0.00 (0.00%)
After-Hours: 17:16
Veracyte Debt to Equity Ratio : 0.0289 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0289 |
| March 31, 2026 | 0.0293 |
| December 31, 2025 | 0.0303 |
| September 30, 2025 | 0.0322 |
| June 30, 2025 | 0.0415 |
| March 31, 2025 | 0.0423 |
| December 31, 2024 | 0.0431 |
| September 30, 2024 | 0.0167 |
| June 30, 2024 | 0.0183 |
| March 31, 2024 | 0.0126 |
| December 31, 2023 | 0.0121 |
| September 30, 2023 | 0.013 |
| June 30, 2023 | 0.0137 |
| March 31, 2023 | 0.0127 |
| December 31, 2022 | 0.0137 |
| September 30, 2022 | 0.0159 |
| June 30, 2022 | 0.0165 |
| March 31, 2022 | 0.017 |
| December 31, 2021 | 0.0172 |
| September 30, 2021 | 0.017 |
| June 30, 2021 | 0.0177 |
| March 31, 2021 | 0.0182 |
| December 31, 2020 | 0.0292 |
| September 30, 2020 | 0.0299 |
| June 30, 2020 | 0.0576 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0579 |
| December 31, 2019 | 0.0568 |
| September 30, 2019 | 0.0604 |
| June 30, 2019 | 0.0636 |
| March 31, 2019 | 0.3213 |
| December 31, 2018 | 0.317 |
| September 30, 2018 | 0.3182 |
| June 30, 2018 | 0.9788 |
| March 31, 2018 | 0.8414 |
| December 31, 2017 | 0.6782 |
| September 30, 2017 | 0.5927 |
| June 30, 2017 | 0.5315 |
| March 31, 2017 | 0.4827 |
| December 31, 2016 | 0.4283 |
| September 30, 2016 | 0.8296 |
| June 30, 2016 | 0.7309 |
| March 31, 2016 | 0.5646 |
| December 31, 2015 | 0.0981 |
| September 30, 2015 | 0.0865 |
| June 30, 2015 | 0.0764 |
| March 31, 2015 | 0.1411 |
| December 31, 2014 | 0.119 |
| September 30, 2014 | 0.1037 |
| June 30, 2014 | 0.1104 |
| March 31, 2014 | 0.0981 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Globus Medical, Inc. | 0.0235 |
| Recursion Pharmaceuticals, Inc. | 0.0728 |
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |
| Teleflex, Inc. | 0.989 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.486B |
| Total Liabilities (Quarterly) | 97.96M |
| Shareholders Equity (Quarterly) | 1.388B |
| Current Ratio | 9.162 |
| Net Debt Paydown Yield | 0.04% |